APPENDIX F.

ILIOFEMORAL DVT SUBGROUP: CONTINUOUS TRIAL OUTCOMES, ANGIOJET-PCDT (ANY METHOD) VERSUS CONTROL

Outcome	Control* (n = 100)		PCDT (n = 95)		PCDT: control difference
	n	Mean (SE)	n	Mean (SE)	Mean difference (SE)	P value
Villalta scale score
At 6 mo	74	4.89 (0.54)	72	4.06 (0.53)	−0.84 (0.55)	.13
At 12 mo	68	4.90 (0.52)	63	3.96 (0.51)	−0.94 (0.50)	.06
At 18 mo	63	4.91 (0.55)	56	3.86 (0.54)	−1.05 (0.57)	.06
At 24 mo	66	4.92 (0.63)	48	3.76 (0.61)	−1.16 (0.71)	.10
VCSS score
At 6 mo	86	3.03 (0.39)	62	2.54 (0.35)	0.49 (0.45)	.27
At 12 mo	74	3.00 (0.39)	52	2.49 (0.36)	0.51 (0.46)	.27
At 18 mo	66	3.34 (0.40)	45	2.61 (0.38)	0.73 (0.48)	.13
At 24 mo	63	2.78 (0.40)	43	2.50 (0.39)	0.27 (0.49)	.57
VEINES-QOL
At 1 mo	86	7.00 (2.46)	73	19.64 (2.36)	12.64 (3.20)	.0001
At 6 mo	74	20.58 (2.67)	63	26.75 (2.5)	6.17 (3.42)	.07
At 12 mo	66	26.48 (2.66)	55	28.23 (2.49)	1.75 (3.34)	.60
At 18 mo	63	26.16 (2.61)	48	29.3 (2.46)	3.14 (3.19)	.33
At 24 mo	66	25.85 (2.87)	47	30.37 (2.74)	4.52 (3.53)	.20
VEINES symptoms
At 1 mo	86	5.87 (2.47)	73	17.27 (2.37)	11.40 (3.13)	.0003
At 6 mo	74	15.63 (2.44)	63	20.06 (2.30)	4.43 (3.02)	.14
At 12 mo	66	16.61 (2.38)	55	20.72 (2.25)	4.12 (2.88)	.15
At 18 mo	63	17.58 (2.56)	48	21.39 (2.44)	3.81 (3.11)	.22
At 24 mo	66	18.56 (2.93)	47	22.06 (2.81)	3.50 (3.64)	.34

DVT = deep vein thrombosis; PCDT = pharmacomechanical catheter-directed venous thrombolysis; QOL = quality of life; SE = standard error; VCSS = venous clinical severity scale; VEINES = Venous Insufficiency Epidemiologic and Economic Study; VEINES-QOL = Venous Insufficiency Epidemiologic and Economic Study-Quality of Life.

^*Treatment groups are per-protocol patients.